Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trial data breached



  • Novo Nordisk cyberattack exposed pseudonymized clinical trial patient data (IDs, biomarkers, lifestyle factors)
  • The company insists that no direct PII was leaked, reducing the immediate risk of phishing or identity misuse.
  • Systems closed by containment; External experts investigate, core operations are not affected.

Novo Nordisk, one of the world's largest pharmaceutical companies, confirmed that it recently suffered a cyberattack in which it lost confidential data belonging to clinical trial patients.

The company claims that the data is pseudonymized and, as such, cannot be used in phishing scams or other tracking attacks.

scroll to top